With a major pandemic sweeping the world, the standard process of clinical trials for drug approval has come under criticism as a needless source of bureaucracy and delay. Drug discovery chemist Derek Lowe in a blog post explains how clinical trials for drug approval work and the reasons behind the various requirements that the FDA and equivalent organisations around the world generally put in place before approving a new drug. He explains how most of these apparently pointless bureaucratic hurdles are actually there to help protect the integrity of the scientific process and ensure that the human subjects undergoing the trials are treated ethically. While a case can be made for relaxing some of these safeguards, especially in this time of pandemic, it is probably not a good idea to do so without at least understanding what these safeguards are for.
Determining how much of a pharmaceutical is needed to prepare for the trial. Ensuring your are actually preparing just that drug and not a polymorph. Proper laboratory and manufacturing practices to ensure the desired drug is actually prepared without impurities and contaminants. Preparing a plan for a drug trial. Demographics — age, gender, weight, current medications being taken. Getting a representative distribution of these as participants. And there's much more.
(Score: 2) by driverless on Sunday May 03 2020, @12:34PM (1 child)
I don't think we'll ever really find out whether those studies were useful or not: Can you see the NEJM publishing a paper "Nazi Medical Research Was Actually Quite Useful In Some Cases"? Certainly after the war the Allies scrambled to get their hands on the Nazi study data, and former Unit 731 members were snapped up by the US, so there was obviously some use for it. "Totally unethical but now it's been done, may as well use it".
(Score: 0) by Anonymous Coward on Sunday May 03 2020, @02:29PM